bluebird bio Inc
NASDAQ:BLUE
bluebird bio Inc
NASDAQ:BLUE
Price:
1.06 USD
-5.36%
Market Closed
Updated:
May 13, 2024
Balance Sheet
Balance Sheet Decomposition
bluebird bio Inc
bluebird bio Inc
| Current Assets | 247.1m |
| Cash & Short-Term Investments | 174.2m |
| Receivables | 23m |
| Other Current Assets | 49.9m |
| Non-Current Assets | 366.5m |
| PP&E | 304.7m |
| Intangibles | 11m |
| Other Non-Current Assets | 50.8m |
| Current Liabilities | 159m |
| Accounts Payable | 19.9m |
| Accrued Liabilities | 121.5m |
| Other Current Liabilities | 17.6m |
| Non-Current Liabilities | 232.1m |
| Other Non-Current Liabilities | 232.1m |
Balance Sheet
bluebird bio Inc
bluebird bio Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
206
|
348
|
164
|
279
|
759
|
403
|
327
|
318
|
161
|
113
|
|
| Cash Equivalents |
206
|
348
|
164
|
279
|
759
|
403
|
327
|
318
|
161
|
113
|
|
| Short-Term Investments |
0
|
126
|
354
|
426
|
532
|
983
|
779
|
834
|
138
|
67
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
6
|
6
|
6
|
20
|
30
|
34
|
45
|
64
|
37
|
19
|
|
| Total Current Assets |
212
|
480
|
524
|
724
|
1 323
|
1 419
|
1 152
|
1 216
|
337
|
200
|
|
| PP&E Net |
11
|
16
|
83
|
157
|
200
|
247
|
337
|
347
|
101
|
291
|
|
| PP&E Gross |
11
|
16
|
83
|
157
|
200
|
247
|
337
|
347
|
101
|
291
|
|
| Accumulated Depreciation |
2
|
3
|
7
|
12
|
16
|
29
|
37
|
51
|
20
|
22
|
|
| Intangible Assets |
0
|
28
|
25
|
21
|
17
|
13
|
14
|
10
|
0
|
5
|
|
| Goodwill |
0
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
6
|
6
|
|
| Long-Term Investments |
0
|
18
|
348
|
181
|
324
|
506
|
132
|
123
|
97
|
1
|
|
| Other Long-Term Assets |
2
|
1
|
10
|
23
|
24
|
45
|
79
|
73
|
53
|
52
|
|
| Other Assets |
0
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
6
|
6
|
|
| Total Assets |
224
N/A
|
557
+148%
|
1 002
+80%
|
1 118
+12%
|
1 901
+70%
|
2 243
+18%
|
1 727
-23%
|
1 781
+3%
|
594
-67%
|
555
-7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
3
|
6
|
14
|
13
|
18
|
43
|
22
|
26
|
25
|
|
| Accrued Liabilities |
4
|
13
|
23
|
50
|
55
|
97
|
136
|
150
|
124
|
101
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
26
|
27
|
11
|
11
|
27
|
31
|
44
|
32
|
3
|
2
|
|
| Total Current Liabilities |
35
|
43
|
40
|
75
|
96
|
146
|
224
|
204
|
153
|
128
|
|
| Long-Term Debt |
0
|
0
|
62
|
120
|
155
|
153
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
37
|
21
|
50
|
54
|
27
|
58
|
219
|
223
|
67
|
230
|
|
| Total Liabilities |
73
N/A
|
66
-10%
|
152
+132%
|
249
+64%
|
277
+11%
|
358
+29%
|
442
+24%
|
426
-4%
|
220
-48%
|
359
+63%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
99
|
147
|
314
|
578
|
914
|
1 499
|
2 282
|
2 901
|
3 720
|
3 987
|
|
| Additional Paid In Capital |
250
|
638
|
1 167
|
1 448
|
2 541
|
3 387
|
3 568
|
4 260
|
4 096
|
4 186
|
|
| Other Equity |
0
|
0
|
2
|
1
|
4
|
4
|
2
|
6
|
3
|
4
|
|
| Total Equity |
152
N/A
|
491
+224%
|
851
+73%
|
869
+2%
|
1 623
+87%
|
1 885
+16%
|
1 285
-32%
|
1 355
+5%
|
374
-72%
|
196
-48%
|
|
| Total Liabilities & Equity |
224
N/A
|
557
+148%
|
1 002
+80%
|
1 118
+12%
|
1 901
+70%
|
2 243
+18%
|
1 727
-23%
|
1 781
+3%
|
594
-67%
|
555
-7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
24
|
32
|
37
|
41
|
49
|
55
|
55
|
66
|
71
|
83
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
